Can we get an amen 👇 #pharmaad #advertising #challenger #healthcare
As we keep thinking about HOW keep clear of making yet another "pharma ad," let's be cautious of little tweaks and safe suggestions. Each one takes us a step further into the familiar and deeper into PharmaLand. And yes, we know "people trust puppies." [Shout out to Andy Mathurin for flagging this great promo.]
Dr. Francis Collins talks about the importance of talking and partnering with FDA early on in the drug development process. Hear more from Dr. Collins and other experts in National Organization for Rare Disorders' free online course Rare Disease Drug Development Series: What Patients and Advocates Need to Know! Part 1: Foundations and Pre-Clinical Research is available now at learn.rarediseases.org. #rarediseases #rdcadap #drugdevelopment
The results from the SAD are due early next year! Yesterday the last participant in our SAD completed his final clinic visit marking the end of the clinical part of the study. This is sooner than initially planned. Therefore it´s possible to present these results already in the January-February transition. As for MAD - the second part of the clinical trial - this will be communicated in the second quarter of 2024, as previously communicated. "This is the first information we will receive about LIB-01 in humans, I´m very excited. The analysis and subsequent results represent a rapid and valuable increase in the understanding of our candidate and guides us in the development work ahead", Elin commented the news. Read the pressrelease here: https://lnkd.in/dJh6ei5n #clinicaltrials #pharma #pharmaceutical #drugdevelopment #sexualdysfunctions #erectiledysfunction #prematureejaculation #lifescience #kliniskastudier #läkemedelsutveckling #sexuelladysfunktioner #erektionssvikt #tidigutlösning
The life science sector witnessed a surge in 2023, with 55 novel drugs approved by the FDA, representing one of the highest years on record. Additionally, life science M&A activity peaked at an impressive $135 billion in 2023, marking an 83% increase from the previous year. Download Newmark’s 2023 Year-End National Life Science Market Overview for an insightful analysis into these historic highs and the trends that are defining the industry’s trajectory. #Newmark #NewmarkResearch #LifeSciences #CRE
Now, our Board of Directors announces the intention to perform a rights issue of units equivalent to approximately SEK 125 million before costs and excluding proceeds from the following warrants in the units. The Rights Issue is secured up to approximately 65 percent through subscription commitments from major shareholders, such as Bertil Lindkvist, Tor Finans AB, Torsten Söderberg and the founder of Dicot Jarl Wikberg, and from all members of the Board of Directors and executive management, together with external investors who have provided underwriting undertakings. All and all, this amounts to approximately SEK 81.3 million. The next step is an extraordinary general meeting on August 1, to authorize the Board of Directors to resolve on the Rights Issue. Read the press release here: https://lnkd.in/dngkAXni #dicotnytt #pharma #pharmaceutical #drugdevelopment #sexualdysfunctions #erectiledysfunction #prematureejaculation #lifescience #kliniskastudier #läkemedelsutveckling #sexuelladysfunktioner #erektionssvikt #tidigutlösning
Great summer news! We have now submitted an application for our phase 2a trial, planned to start in quarter four, 2024. The trial is fully funded due to already secured amounts in the rights issue we intend to carry out in August. Read the press release below or here: https://lnkd.in/d3qxECzU #pharma #pharmaceutical #drugdevelopment #sexualdysfunctions #erectiledysfunction #prematureejaculation #lifescience #kliniskastudier #läkemedelsutveckling #sexuelladysfunktioner #erektionssvikt #tidigutlösning
We don´t wait around, to maximize speed we do things in parallel. Before finalizing the phase 1-study, we have started the preparations for a phase 2a trial, planned to commence in the second half of this year. CTC AB is now contracted to conduct the trial and our study drug has already been produced by the contract manufacturer Thermo Fisher Scientific. Read more in the press release: https://lnkd.in/g3sf5drt #clinicaltrials #pharma #pharmaceutical #drugdevelopment #sexualdysfunctions #erectiledysfunction #prematureejaculation #lifescience #kliniskastudier #läkemedelsutveckling #sexuelladysfunktioner #erektionssvikt #tidigutlösning
Behind the Scenes: The Magic Happens Here! Ever wondered what goes on behind the camera? Take a peek at the action, creativity, and hard work that bring our projects to life! 🌟✨ From planning to execution, watch how every detail comes together. #BehindTheScenes #BTS #MakingMagic #CreativeProcess #FilmProduction #Teamwork #OnSet https://lnkd.in/ecKJgxAN
A short film from the fabulous Dealing With Drugs Conference in Amsterdam. Follow the link and the film is on the page
